ERCC6L in human cancers: oncogenic functions, molecular mechanisms, and clinical implications as a prognostic biomarker and therapeutic target
-
By
-
Lingyu Jiang
-
Huaihai Zhou
-
Jing He
-
Junqi Qin
-
Jianwei Huang
-
Jiaping Wei
-
Yifan Zhou
-
Yonglong Zhong
-
July 1, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
The University of Texas MD Anderson Cancer Center
Houston, Texas
-
#2
Memorial Sloan Kettering Cancer Center
New York, New York
-
#3
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, California
-
#4
Fudan University Shanghai Cancer Center
Shanghai, China
-
#5
Vall d’Hebron Institute of Oncology
Barcelona, Spain
